Susana B. Ramalho
Hospital Da Mulher Prof. Dr. José Aristodemo Pinotti
Campinas, SP, Brazil
Campinas, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer.
Journal: Breast cancer research : BCR
Published: January 03, 2026
Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: December 11, 2025
Distribution of HER2 Low in Tumors of Patients With Hereditary Breast Cancer According to Germline Pathogenic or Likely Pathogenic Genetic Variants.
Journal: Clinical breast cancer
Published: December 27, 2024
Prognosis and cardiotoxicity associated to adjuvant trastuzumab for breast cancer: real world study in a public health system.
Journal: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
Published: October 20, 2023
Evaluation of PD-L1 and tumor infiltrating lymphocytes in paired pretreatment biopsies and post neoadjuvant chemotherapy surgical specimens of breast carcinoma.
Journal: Scientific reports
Published: July 06, 2021
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil.
Journal: The oncologist
Published: December 27, 2020
Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer.
Journal: Breast cancer research and treatment
Published: October 28, 2020
Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer.
Journal: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
Published: December 20, 2019
ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy.
Journal: Frontiers in oncology
Published: December 10, 2019
Role of discoidin domain receptor 2 (DDR2) and microRNA-182 in survival of women with high-grade serous ovarian cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: February 28, 2019
Copy number alterations associated with clinical features in an underrepresented population with breast cancer.
Journal: Molecular genetics & genomic medicine
Published: February 01, 2019
Last Updated: 09/26/2026